Off-Target Intelligence INDUCE-seq provides data-driven mapping of off-target edits to support gene editing programs from discovery through clinical development, helping teams de-risk therapies and generate regulatory-ready data.

Early Access The Catalyst Early Access Program creates a direct route to on-site INDUCE-seq services for select gene therapy developers, enabling rapid adoption and the potential to convert pilots into multi-project agreements.

AI Collaboration Ongoing AI partnerships suggest an upsell path for integrated computational optimization of design and screening workflows, offering bundled INDUCE-seq data with AI-driven analysis to shorten development timelines.

EU Partnerships Brand refresh and European collaborations indicate readiness to expand in Europe; target EU biotech labs and CROs for localized support, on-site testing, and grant-funded projects.

Strategic Vendor With growing revenue and leadership evolution, Broken String is positioned to become a strategic vendor for end-to-end data generation in cell and gene therapy programs, enabling long-term collaborations.